(Q53914516)

22 May 2018

title

In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage. (English)

1 reference

22 May 2018

1 reference

2

1 reference

22 May 2018

Gioacchino Calapai

4

1 reference

22 May 2018

author name string

Buemi M

1

1 reference

22 May 2018

Corica F

3

1 reference

22 May 2018

Salpietro FM

5

1 reference

22 May 2018

Casuscelli T

6

1 reference

22 May 2018

Sfacteria A

7

1 reference

22 May 2018

Aloisi C

8

1 reference

22 May 2018

Alafaci C

9

1 reference

22 May 2018

Sturiale A

10

1 reference

22 May 2018

Frisina N

11

1 reference

22 May 2018

Tomasello F

12

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 March 2000

1 reference

22 May 2018

European Journal of Pharmacology

published in

1 reference

22 May 2018

volume

392

1 reference

22 May 2018

issue

1-2

1 reference

22 May 2018

page(s)

31-34

1 reference

22 May 2018

Hemodynamic effects of recombinant human erythropoietin.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Effects of intravenous administration of recombinant human erythropoietin in rats subject to hemorrhagic shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Does erythropoietin augment the Ca(2+)-mediated K+ flow into the red blood cells in normotensive and hypertensive subjects?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Experimental cerebral vasospasm: resolution by iloprost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Behavioral deficits following experimental subarachnoid hemorrhage in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Immunohistochemical localization of erythropoietin and its receptor in the developing human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Erythropoietin gene expression in human, monkey and murine brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

In vivo evidence that erythropoietin protects neurons from ischemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Effect of U88999E on experimental cerebral vasospasm in rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Site-specific effects of local pH changes in the substantia nigra pars reticulata on flurothyl-induced seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900081-9

10.1016/S0014-2999(00)00081-9

7 January 2021

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

10748269

1 reference

22 May 2018